scholarly article | Q13442814 |
P50 | author | Chris Scott | Q57894195 |
P2093 | author name string | H Reuter | |
G Faller | |||
L E Schanberg | |||
A A Kalla | |||
A Phuti | |||
L B Lewandowski | |||
P Nourse | |||
I Okpechi | |||
P Gajjar | |||
G Spittal | |||
N Thielman | |||
P Ambaram | |||
P2860 | cites work | Epidemiology of systemic lupus erythematosus: a comparison of worldwide disease burden | Q22255575 |
Genetic analysis of African populations: human evolution and complex disease | Q28216772 | ||
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus | Q29614922 | ||
Epidemiology treatment and outcome of childhood systemic lupus erythematosus in Egypt | Q33366672 | ||
Systemic lupus erythematosus in Zimbabwe | Q33556851 | ||
Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults. | Q33560549 | ||
Pediatric lupus--are there differences in presentation, genetics, response to therapy, and damage accrual compared with adult lupus? | Q33723511 | ||
Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort | Q33727314 | ||
Recent clinical trials in lupus nephritis | Q33924437 | ||
Genome-wide analysis of the structure of the South African Coloured Population in the Western Cape | Q34116751 | ||
Use of race and ethnicity in epidemiologic research: concepts, methodological issues, and suggestions for research | Q34161959 | ||
Comparison of renal response parameters for juvenile membranous plus proliferative lupus nephritis versus isolated proliferative lupus nephritis: a cross-sectional analysis of the CARRA Registry | Q34324887 | ||
What have we learned from a 10-year experience with the LUMINA (Lupus in Minorities; Nature vs. nurture) cohort? Where are we heading? | Q34332377 | ||
CTLA-4: new insights into its biological function and use in tumor immunotherapy | Q34711491 | ||
Racial/Ethnic variation in all-cause mortality among United States medicaid recipients with systemic lupus erythematosus: a Hispanic and asian paradox. | Q35195820 | ||
Increased risk of death in African American patients with end-stage renal disease secondary to lupus | Q35310917 | ||
Outcome in juvenile onset systemic lupus erythematosus | Q36225769 | ||
Demographics and presenting clinical features of childhood systemic lupus erythematosus. | Q36229638 | ||
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus | Q36278355 | ||
The ISN/RPS 2003 classification of lupus nephritis: an assessment at 3 years | Q36723156 | ||
Comparing genetic ancestry and self-described race in african americans born in the United States and in Africa | Q36828761 | ||
Lupus in the developing world--is it any different? | Q37265652 | ||
Improving outcomes in patients with lupus and end-stage renal disease | Q37522782 | ||
The geoepidemiology of systemic lupus erythematosus | Q37662978 | ||
Childhood- and adult-onset lupus: an update of similarities and differences. | Q37754678 | ||
Pediatric SLE--towards a comprehensive management plan | Q37850999 | ||
Lupus nephritis and end-stage kidney disease | Q38078211 | ||
A bibliometric study of literature on SLE research in PubMed (2002-2011). | Q38113485 | ||
Patterns of systemic lupus erythematosus expression in Europe | Q38177964 | ||
Diagnosis and management of neuropsychiatric SLE. | Q38186995 | ||
Juvenile systemic lupus erythematosus: onset patterns and short-term outcome in Egyptian children, a single-center experience | Q38854545 | ||
Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa? | Q38947966 | ||
Juvenile systemic lupus erythematosus among Egyptian children. | Q38987318 | ||
Systemic lupus erythematosus in Egyptian children | Q39423577 | ||
Systemic lupus erythematosus with nephritis in children. A report of 6 cases | Q39788684 | ||
Pattern of systemic lupus erythematosus among Nigerians | Q40396348 | ||
Systemic lupus erythematosus in a black South African child. First documented case report. | Q40752511 | ||
Systemic lupus erythematosus and lupus syndromes in Senegal. A retrospective study of 30 patients seen over 10 years. | Q40838609 | ||
Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE. | Q40909861 | ||
Outcome of patients with membranous lupus nephritis in Cape Town South Africa | Q41929518 | ||
Ethnic differences in pediatric systemic lupus erythematosus | Q43796417 | ||
Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study | Q43838569 | ||
Longterm followup of childhood lupus nephritis. | Q44237962 | ||
Lupus in Africa: can we dispel the myths and face the challenges? | Q44398366 | ||
Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE). | Q44800972 | ||
Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort | Q45812853 | ||
Hydroxychloroquine: the cornerstone of lupus therapy | Q46643929 | ||
Challenges of ethnicity in SLE. | Q46690937 | ||
The dangers of rationing dialysis treatment: the dilemma facing a developing country. | Q50929417 | ||
Systemic lupus erythematosus in children. A report of 3 cases | Q54586489 | ||
The epidemiology of systemic lupus erythematosus in populations of African ancestry: A critical review of the ?prevalence gradient hypothesis? | Q57331151 | ||
The Use of Race in Medical Research | Q67717648 | ||
A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus | Q70724611 | ||
SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus | Q71055756 | ||
High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus | Q74508440 | ||
Mortality patterns in childhood lupus--10 years' experience in a developing country | Q78560061 | ||
Damage did not independently influence mortality in childhood systemic lupus erythematosus | Q81387175 | ||
Paediatric rheumatic disease: lessons from SLE: children are not little adults | Q84561164 | ||
Effect of renal disease on the standardized mortality ratio and life expectancy of patients with systemic lupus erythematosus | Q86932194 | ||
P433 | issue | 2 | |
P921 | main subject | South Africa | Q258 |
pediatric systemic lupus erythematosus | Q55788836 | ||
P304 | page(s) | 186-194 | |
P577 | publication date | 2016-08-19 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Severe disease presentation and poor outcomes among pediatric systemic lupus erythematosus patients in South Africa | |
P478 | volume | 26 |
Q39010807 | Advances in the care of children with lupus nephritis |
Q98163842 | Improving musculoskeletal health for children and young people - A 'call to action' |
Q46867176 | Juvenile systemic lupus erythematosus in Turkey: demographic, clinical and laboratory features with disease activity and outcome. |
Q30839806 | Missed opportunities for timely diagnosis of pediatric lupus in South Africa: a qualitative study |
Q60173972 | Pediatric lupus nephritis |
Search more.